About 16% of people with multiple sclerosis may have trouble tasting food, which can affect their appetite and overall health.
The study found that 16.4% of people with multiple sclerosis (MS) experience problems with their sense of taste. This can lead to not wanting to eat, which might cause weight loss and poor nutrition, similar to how a kid might refuse to eat broccoli if it tastes bad. The researchers discovered that specific tests showed even higher rates of taste issues in some cases, like 18.8% when using the Taste Strip Test, which is like a fun taste test game. Compared to healthy people, those with MS scored much lower on taste tests, meaning they have a harder time tasting different flavors. This suggests that taste problems are common in MS and can affect how well someone eats and enjoys food.
MS patients should care about this study because it highlights a common issue that might be affecting their eating habits and health. If you or someone you care for struggles to taste food, it could lead to not eating enough, just like how we might skip meals if our favorite foods don’t taste good. Caregivers can use this information to help encourage better eating habits or seek help if someone is losing weight. Healthcare providers can also look for taste issues during check-ups, which could lead to better support for managing nutrition. Overall, understanding this symptom can lead to improved quality of life for people with MS.
The study looked at a variety of research, which means results might differ based on how taste was tested. Some people with MS might not feel comfortable talking about taste problems, so the actual number could be higher. It's important for MS patients and caregivers to recognize that taste issues can be managed, and support is available.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/1/2026
Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read More3/1/2026
Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog
Read More3/1/2026
Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo
Read More3/1/2026
Discover how new research could help women with MS produce more IL-10, an important substance for co
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Chemical senses often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.